Arecor secures £6m investment for clinical development of its diabetes portfolio

Arecor secures £6m investment for clinical development of its diabetes portfolio

Arecor Ltd, the UK-based leader in developing superior biopharmaceuticals through the application of an innovative formulation technology platform, today announces that it has secured £6 million of investment from new and existing investors for the clinical development of the Company’s speciality pharma portfolio of proprietary diabetes products.